Clinical trial
Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass
NCT03898024 is registered in ClinicalTrials.gov with Second Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass
- Lead sponsor
- Second Xiangya Hospital of Central South University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 15, 2019
- Completion date
- August 15, 2020
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoporosis, osteopenia